INKT · Insider trading · 13F holders · Congress trades
MiNK Therapeutics, Inc. (INKT)
Who is buying and selling INKT: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $73K
- Congress trades, 12 months
- 0
INKT at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 INKT insider filed 1 sale worth $73K on SEC Form 4, and no open-market purchases.
- No 13F filer reports INKT among its 50 largest positions.
- No member of Congress has disclosed a trade in INKT.
- INKT last closed at $10.88 on Oct 29, 2026.
INKT insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 INKT insider filed 1 sale worth $73K on SEC Form 4, and no open-market purchases.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Buell Jennifer | Chief Executive Officer, Director | Sale | 6,938 | $10.56 | $73K | SEC |
Who owns INKT? Hedge funds and superinvestors
No 13F filer reports INKT among its 50 largest positions.
INKT stock trades by members of Congress
No member of Congress has disclosed a trade in INKT.
INKT questions and answers
Are insiders buying INKT stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 INKT insider filed 1 sale worth $73K on SEC Form 4, and no open-market purchases.
Which hedge funds own INKT?
No 13F filer reports INKT among its 50 largest positions.
Has Congress traded INKT?
No member of Congress has disclosed a trade in INKT.
Cite or share this
Free to use with a link back. The data updates every filing day.